Condition: Hematologic Malignancies · Inherited Disorders of Metabolism · Inherited Abnormalities of Platelets · Sponsor: Center for International Blood and Marrow Transplant Research
This study is an access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) in pediatric and adult patients with hematologic malignancies and other indications.
This description comes directly from the study's public registry record.
Elizabeth Fosberg, B.A. · 10-CBA@ndmp.org
Always discuss trial participation with your own doctor first.
| University of Alabama at Birmingham | Birmingham, Alabama, United States | Recruiting |
| Banner MD Anderson Cancer Center | Gilbert, Arizona, United States | Recruiting |
| Phoenix Children's Hospital | Phoenix, Arizona, United States | Recruiting |
| Mayo Clinic Arizona (adults) | Phoenix, Arizona, United States | Withdrawn |
| University of Arizona Medical Center - Tucson | Tucson, Arizona, United States | Recruiting |
| Arkansas Children's Hospital | Little Rock, Arkansas, United States | Recruiting |
| City of Hope | Duarte, California, United States | Recruiting |
| Children's Hospital of Los Angeles | Glendale, California, United States | Recruiting |
| Scripps Green Hospital | La Jolla, California, United States | Recruiting |
| University of California San Diego | La Jolla, California, United States | Recruiting |
| Loma Linda University Cancer Center | Loma Linda, California, United States | Recruiting |
| UCLA | Los Angeles, California, United States | Recruiting |
+ 130 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT01351545